Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP548578.RASmETYF6jhOjlEULjUpEUkS96CYhDacp9MYAr61PtPrE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP548578.RASmETYF6jhOjlEULjUpEUkS96CYhDacp9MYAr61PtPrE130_assertion type Assertion NP548578.RASmETYF6jhOjlEULjUpEUkS96CYhDacp9MYAr61PtPrE130_head.
- NP548578.RASmETYF6jhOjlEULjUpEUkS96CYhDacp9MYAr61PtPrE130_assertion description "[We noted that the disease also contributed to decreased CuZn SOD activity in SALS patients in comparison with the control group (two-way ANOVA, mutation and disease effect).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548578.RASmETYF6jhOjlEULjUpEUkS96CYhDacp9MYAr61PtPrE130_provenance.
- NP548578.RASmETYF6jhOjlEULjUpEUkS96CYhDacp9MYAr61PtPrE130_assertion evidence source_evidence_literature NP548578.RASmETYF6jhOjlEULjUpEUkS96CYhDacp9MYAr61PtPrE130_provenance.
- NP548578.RASmETYF6jhOjlEULjUpEUkS96CYhDacp9MYAr61PtPrE130_assertion SIO_000772 16681429 NP548578.RASmETYF6jhOjlEULjUpEUkS96CYhDacp9MYAr61PtPrE130_provenance.
- NP548578.RASmETYF6jhOjlEULjUpEUkS96CYhDacp9MYAr61PtPrE130_assertion wasDerivedFrom befree-2016 NP548578.RASmETYF6jhOjlEULjUpEUkS96CYhDacp9MYAr61PtPrE130_provenance.
- NP548578.RASmETYF6jhOjlEULjUpEUkS96CYhDacp9MYAr61PtPrE130_assertion wasGeneratedBy ECO_0000203 NP548578.RASmETYF6jhOjlEULjUpEUkS96CYhDacp9MYAr61PtPrE130_provenance.